eNews
Home page > Comments


Comments

French health body favors reimbursement of InterMune lung drug

06.04.2012. | (Reuters) - InterMune Inc said French health authorities ruled in favor of reimbursing the company's lung scarring drug Esbriet, potentially covering its costs in a country that is scaling back healthcare spending....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: